Receptor sites for Ca2+ channel antagonists

https://doi.org/10.1016/0165-6147(92)90079-LGet rights and content

Abstract

Ca2+ channel antagonist drugs inhibit voltage-gated Ca2+ channels in many different cell types. Inhibition of Ca2+ channels in smooth muscle and cardiac muscle cells by these drugs is valuable in the therapy of a wide range of cardiovascular disorders including hypertension, atrial arrhythmia and angina pectoris. Additional uses under evaluation are protection against ischemic damage during myocardial infarction and stroke and in a wide range of other conditions. Further understanding of the sites and mechanisms of action of Ca2+ channel antagonists, as described in this review by Bill Catterall and Jörg Striessnig, will provide new insight into the design of novel therapeutic agents acting on Ca2+ channels and provide further understanding of Ca2+ channel structure and function.

References (36)

  • R.W. Tsien et al.

    Trends Pharmacol. Sci.

    (1991)
  • L.G. Herbette et al.

    J. Mol. Cell. Cardiol.

    (1989)
  • J. Striessnig

    FEBS Lett.

    (1987)
  • J.P. Galizzi et al.

    J. Biol. Chem.

    (1986)
  • P.L. Vaghy

    J. Biol. Chem.

    (1987)
  • A.H. Sharp et al.

    J. Biol. Chem.

    (1987)
  • E.R. Kantrowitz et al.

    Trends Biochem. Sci.

    (1990)
  • L.N. Johnson et al.

    J. Biol. Chem.

    (1990)
  • T. Hoshi et al.

    Neuron

    (1991)
  • K. Naito et al.

    J. Biol. Chem.

    (1989)
  • J. Striessnig et al.

    J. Biol. Chem.

    (1990)
  • L.M. Hondeghem et al.

    Annu. Rev. Pharmacol. Toxicol.

    (1984)
  • K.S. Lee et al.

    Nature

    (1983)
  • J. Hescheler et al.

    Pflugers Arch.

    (1982)
  • D.J. Triggle et al.

    Annu. Rev. Pharmacol. Toxicol.

    (1987)
  • B.P. Bean
  • P. Hess et al.

    Nature

    (1984)
  • R.S. Kass et al.

    J. Gen. Physiol.

    (1989)
  • Cited by (351)

    • Design, synthesis, and anticancer activity of iridium(III) complex-peptide hybrids that contain hydrophobic acyl groups at the N-terminus of the peptide units

      2019, Journal of Inorganic Biochemistry
      Citation Excerpt :

      It is described that programed cell death can be classified into apoptosis, necroptosis, paraptosis, autophagic cell death, and so on [26–51]. In our previous study, we reported that cell death induced by 3a (with a peptide at the 5′-position) was not inhibited by a broad caspase inhibitor, Z-VAD-fmk [18], while inhibition was observed in the presence some inhibitors related to Ca2+ homeostasis including 3-chlorophenylhydrazone (CCCP, an uncoupling reagent and an inhibitor of mitochondrial Ca2+ uptake) [44,45], verapamil (an L-type voltage-operated Ca2+ channel blocker) [46–48], quinidine (a Na+ and K+ channel blocker) [49,50] and xestospongin C (a selective inhibitor of the IP3 receptor on the ER which releases Ca2+ into the cytosol) [51,52]. Based on these data, it was concluded that 3a negligibly induces apoptosis but involves cell death that is mediated by Ca2+-dependent signaling pathways.

    • A cell-based assay for the detection of pathogenic anti-voltage-gated calcium channel autoantibodies in immunoglobulin G from patients with type 1 diabetes

      2018, Journal of Immunological Methods
      Citation Excerpt :

      Co-incubation of cells with both Bay K8644 and nicardipine reduced the number of DCF-DA positive cells compared to Bay K8644 alone, with a significant reduction in DCF-DA positive cells achieved at 10 nM nicardipine (Fig. 1 B). Previous studies have demonstrated that the serum, or the IgG fraction, from patients with T1D contains a functional Ab that acts as an agonist at the DHP binding site of L-Type VGCCs, and disrupts channel-mediated physiological responses in live tissue or cell-based assays (Catterall and Striessnig, 1992; Jackson et al., 2004; Jackson and Gordon, 2010). Recent reports indicate that these anti-VGCC Abs are capable of mediating over-activity of VGCCs in cultured pancreatic β cell lines, resulting in altered ion exchange and induction of apoptosis (Chang et al., 2004; Bason et al., 2013; Yang et al., 2015).

    • Use of calcium channel blockers for glaucoma

      2011, Progress in Retinal and Eye Research
    • Olive Oil Phenols and Nitric Oxide Affect Lymphomonocyte Cytosolic Calcium

      2010, Olives and Olive Oil in Health and Disease Prevention
    View all citing articles on Scopus
    View full text